血浆炎症蛋白分析揭示可预测后续巨细胞动脉炎发生的生物标志物:一项前瞻性研究
在基于人群的马尔默饮食与癌症研究(MDCS,N=30 447)中,识别94例后续确诊巨细胞动脉炎(GCA)者并按性别、出生年、筛查年匹配无GCA对照,用OLINK炎症蛋白panel检测基线血浆。预先假设分析中IFN-γ每升高1个标准差与GCA风险正相关(OR 1.52;95%CI 1.00,2.30);假设生成分析中IFN-γ(OR 2.37;95%CI 1.14,4.92)与MCP3(OR 4.27;95%CI 1.26,14.53)在诊断前<8.5年亚组与GCA风险升高相关。结论认为GCA诊断前数年即可见IFN-γ升高,T细胞激活可能先于临床发病。
要点
- 基线血浆IFN-γ每升高1个标准差与后续GCA风险正相关(OR 1.52;95%CI 1.00,2.30)。
- 诊断前<8.5年亚组中,IFN-γ(OR 2.37;95%CI 1.14,4.92)和MCP3(OR 4.27;95%CI 1.26,14.53)与GCA风险升高相关。
- CXCL9、IL-2、CD40、CCL25等T细胞功能相关蛋白亦与GCA相关,T细胞激活可能先于临床发病。
核心结论
- GCA诊断前数年即可检测到IFN-γ水平升高,T细胞激活可能先于GCA临床发病。
研究设计与样本
- 采用基于抗体的OLINK蛋白组学炎症panel(92种炎症蛋白)检测基线血浆样本,分析预先设定为假设驱动或假设生成两类。
- 假设生成分析采用主成分分析识别解释蛋白组变异的蛋白组,在按特征值选出的成分内考察因子载荷>0.50的蛋白。
主要发现
- 共识别94例确诊为GCA的病例,确诊距入组中位11.9年。
- 在预先假设的生物标志物中,IFN-γ与GCA正相关(每升高1个标准差OR 1.52;95%CI 1.00,2.30)。
- 假设生成分析中有8种生物标志物与GCA发生显著相关。
- 在诊断前<8.5年采样的亚组中,较高水平的IFN-γ(OR 2.37;95%CI 1.14,4.92)和单核细胞趋化蛋白3(MCP3)(OR 4.27;95%CI 1.26,14.53)与GCA风险升高尤其相关。
- CXCL9、IL-2、CD40和CCL25等已知对T细胞功能重要的其他蛋白在这些分析中亦与GCA相关。
关键数值与推荐
- 预先假设分析:IFN-γ每升高1个标准差与GCA的OR为1.52(95%CI 1.00,2.30)。
- 假设生成分析诊断前<8.5年亚组:IFN-γ的OR为2.37(95%CI 1.14,4.92),MCP3的OR为4.27(95%CI 1.26,14.53)。
- 假设生成分析中共8种生物标志物与GCA发生显著相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the relation between biomarkers of inflammation and subsequent development of GCA. METHOD: Participants in the population-based Malmö Diet Cancer Study (MDCS; N = 30 447), established 1991-96, who were subsequently diagnosed with GCA, were identified in a structured process. GCA-free controls, matched for sex, year of birth and year of screening were selected from the study cohort. Baseline plasma samples were analysed using the antibody-based OLINK proteomics inflammation panel (92 inflammatory proteins). Analyses were pre-designated as hypothesis-driven or hypothesis-generating. In the latter, principal component analysis was used to identify groups of proteins that explain the variance in the proteome. Within components selected based on eigenvalues, proteins with a factor loading of >0.50 were investigated. RESULTS: Ninety-four cases with a confirmed incident diagnosis of GCA (median 11.9 years after inclusion) were identified. Among biomarkers with a priori hypotheses, IFN-γ was positively associated with GCA [odds ratio (OR) per s.d. 1.52; 95% CI 1.00, 2.30]. Eight biomarkers in the hypothesis-generating analyses were significantly associated with development of GCA. Among these, higher levels of IFN-γ (OR 2.37; 95% CI 1.14, 4.92) and monocyte chemotactic protein 3 (MCP3) (OR 4.27; 95% CI 1.26, 14.53) were particularly associated with increased risk of GCA in the subset sampled <8.5 years before diagnosis. Several other proteins known to be important for T cell function were also associated with GCA in these analyses, e.g. CXCL9, IL-2, CD40 and CCL25. CONCLUSION: Elevated IFN-γ levels were found years prior to diagnosis of GCA. T cell activation may precede the clinical onset of GCA.
引用
- Wadström K, Jacobsson LTH, Mohammad AJ, et al. Analyses of plasma inflammatory proteins reveal biomarkers predictive of subsequent development of giant cell arteritis: a prospective study. Rheumatology (Oxford). 2023. PMID: 36255228. doi:10.1093/rheumatology/keac581
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。